136 related articles for article (PubMed ID: 38754869)
21. A systematic review of quantitative bias analysis applied to epidemiological research.
Petersen JM; Ranker LR; Barnard-Mayers R; MacLehose RF; Fox MP
Int J Epidemiol; 2021 Nov; 50(5):1708-1730. PubMed ID: 33880532
[TBL] [Abstract][Full Text] [Related]
22. The confounder matrix: A tool to assess confounding bias in systematic reviews of observational studies of etiology.
Petersen JM; Barrett M; Ahrens KA; Murray EJ; Bryant AS; Hogue CJ; Mumford SL; Gadupudi S; Fox MP; Trinquart L
Res Synth Methods; 2022 Mar; 13(2):242-254. PubMed ID: 34954912
[TBL] [Abstract][Full Text] [Related]
23. Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers.
Thorlund K; Duffield S; Popat S; Ramagopalan S; Gupta A; Hsu G; Arora P; Subbiah V
J Comp Eff Res; 2024 Mar; 13(3):e230147. PubMed ID: 38205741
[TBL] [Abstract][Full Text] [Related]
24. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias?
Masarwa R; Platt RW; Filion KB
Paediatr Perinat Epidemiol; 2020 May; 34(3):309-317. PubMed ID: 31916282
[TBL] [Abstract][Full Text] [Related]
25. Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.
Hossain MB; Mosquera L; Karim ME
BMC Med Res Methodol; 2022 Feb; 22(1):46. PubMed ID: 35172746
[TBL] [Abstract][Full Text] [Related]
26. Understanding the impact of non-shared unmeasured confounding on the sibling comparison analysis.
Esen BÖ; Ehrenstein V; Petersen I; Sørensen HT; Pedersen L
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38110565
[TBL] [Abstract][Full Text] [Related]
27. Causal Modeling to Mitigate Selection Bias and Unmeasured Confounding in Internet-Based Epidemiology of COVID-19: Model Development and Validation.
Stockham N; Washington P; Chrisman B; Paskov K; Jung JY; Wall DP
JMIR Public Health Surveill; 2022 Jul; 8(7):e31306. PubMed ID: 35605128
[TBL] [Abstract][Full Text] [Related]
28. Bounding formulas for selection bias.
Huang TH; Lee WC
Am J Epidemiol; 2015 Nov; 182(10):868-72. PubMed ID: 26519426
[TBL] [Abstract][Full Text] [Related]
29. Confounding and regression adjustment in difference-in-differences studies.
Zeldow B; Hatfield LA
Health Serv Res; 2021 Oct; 56(5):932-941. PubMed ID: 33978956
[TBL] [Abstract][Full Text] [Related]
30. Estimating and correcting for confounder misclassification.
Savitz DA; Barón AE
Am J Epidemiol; 1989 May; 129(5):1062-71. PubMed ID: 2705426
[TBL] [Abstract][Full Text] [Related]
31. Bias--is it a problem, and what should we do?
Dohoo IR
Prev Vet Med; 2014 Feb; 113(3):331-7. PubMed ID: 24176138
[TBL] [Abstract][Full Text] [Related]
32. Illustrating How to Simulate Data From Directed Acyclic Graphs to Understand Epidemiologic Concepts.
Fox MP; Nianogo R; Rudolph JE; Howe CJ
Am J Epidemiol; 2022 Jun; 191(7):1300-1306. PubMed ID: 35259232
[TBL] [Abstract][Full Text] [Related]
33. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
[TBL] [Abstract][Full Text] [Related]
34. Multiple-bias Sensitivity Analysis Using Bounds.
Smith LH; Mathur MB; VanderWeele TJ
Epidemiology; 2021 Sep; 32(5):625-634. PubMed ID: 34224471
[TBL] [Abstract][Full Text] [Related]
35. Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review.
Hunnicutt JN; Ulbricht CM; Chrysanthopoulou SA; Lapane KL
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1343-1353. PubMed ID: 27593968
[TBL] [Abstract][Full Text] [Related]
36. Bias Formulas for Estimating Direct and Indirect Effects When Unmeasured Confounding Is Present.
le Cessie S
Epidemiology; 2016 Jan; 27(1):125-32. PubMed ID: 26426943
[TBL] [Abstract][Full Text] [Related]
37. Mismeasurement and the resonance of strong confounders: correlated errors.
Marshall JR; Hastrup JL; Ross JS
Am J Epidemiol; 1999 Jul; 150(1):88-96. PubMed ID: 10400558
[TBL] [Abstract][Full Text] [Related]
38. Sources of confounding in life course epidemiology.
Santos S; Zugna D; Pizzi C; Richiardi L
J Dev Orig Health Dis; 2019 Jun; 10(3):299-305. PubMed ID: 30111382
[TBL] [Abstract][Full Text] [Related]
39. Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.
Yu M; Xie D; Wang X; Weiner MG; Tannen RL
Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():60-8. PubMed ID: 22552981
[TBL] [Abstract][Full Text] [Related]
40. Synthetic Negative Controls: Using Simulation to Screen Large-scale Propensity Score Analyses.
Wyss R; Schneeweiss S; Lin KJ; Miller DP; Kalilani L; Franklin JM
Epidemiology; 2022 Jul; 33(4):541-550. PubMed ID: 35439779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
